These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15625845)

  • 1. [The implication of circulating CD34+ Thy-1(+) cells measurement during autologous peripheral blood stem cell mobilization].
    Yang B; Wang L; Chen P
    Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):406-9. PubMed ID: 15625845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK; Imrie K; Keating A; Anania S; Nayar R; Sutherland DR
    Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization.
    Rossi G; Skert C; Morello E; Almici C; Arcaini L; Basilico C; Cavalli L; Botto B; Castelli A; Pica G; Ripamonti F; Salvi F; Carella AM; Gaidano G; Levis A; Nosari A; Russo D; Vitolo U
    Hematol Oncol; 2015 Sep; 33(3):125-32. PubMed ID: 24890497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors.
    Seong C; Durett A; Mirza N; Huh Y; Anderlini P; Champlin R
    Transfusion; 1997 Apr; 37(4):406-10. PubMed ID: 9111278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
    Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
    J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CDw90 (Thy-1) expression on CD34 positive cells in peripheral blood stem cell harvest].
    Miyamoto K; Otsuka T; Mizuno S; Funatsu K; Inaba R
    Rinsho Ketsueki; 1997 Jan; 38(1):9-13. PubMed ID: 9028155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.
    Sampol Mayol A; Besalduch Vital J; Galmés Llodrá A; Bargay Lleonart J; Matamoros Flori N; Morey Sureda M; Novo García A; Mascaró Riera M; Gonzaléz Bach E; Martínez García P
    Haematologica; 1998 Jun; 83(6):489-95. PubMed ID: 9676020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
    Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
    Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobilization and harvesting of peripheral blood stem cells.
    Moog R
    Curr Stem Cell Res Ther; 2006 May; 1(2):189-201. PubMed ID: 18220866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
    Demirer T; Buckner CD; Gooley T; Appelbaum FR; Rowley S; Chauncey T; Lilleby K; Storb R; Bensinger WI
    Bone Marrow Transplant; 1996 Jun; 17(6):937-41. PubMed ID: 8807097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thy-1 (CDw90) and c-kit receptor (CD117) expression on CD34+ hematopoietic progenitor cells: a five dimensional flow cytometric study.
    D'Arena G; Musto P; Cascavilla N; Carotenuto M
    Haematologica; 1998 Jul; 83(7):587-92. PubMed ID: 9718862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management strategies for poor peripheral blood stem cell mobilization.
    Moog R
    Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
    Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A;
    Cytotherapy; 2010; 12(1):50-9. PubMed ID: 19878077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with successful mobilization of progenitor hematopoietic stem cells among patients with lymphoid malignancies.
    Ameen RM; Alshemmari SH; Alqallaf D
    Clin Lymphoma Myeloma; 2008 Apr; 8(2):106-10. PubMed ID: 18501104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.